Skip to main content

Table 1 Demographic and clinicopathologic characteristics of HCC patients in the initial training set

From: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters

Variable Name

Mean ± SD/Median or %

Variable Name

Percentage

Survival (month)

33.8 ± 29.4/25.3

Event

 

Disease free survival (month)

25.0 ± 28.9/11.7

   Deceased

32.2

Age (year)

56.0 ± 12.0/56

   Censored

67.8

Male

80.4%

Child's grade

 

Liver Function Parameters

 

   A

97.3

   AFP [log10] (ng/mL)

2.18 ± 1.39/2.03

   B

2.7

   SGPT (U/L)

61.0 ± 51.4/46

Family History of HCC

20.7

   SGOT (U/L)

64.3 ± 53.9/49

Smoking

 

   BILIRUBIN (μM)

14.5 ± 11.2/12

   No

55.6

   ALBUMIN (mg/mL)

40.2 ± 4.7/41

   Moderate

30.5

  

   Heavy

13.9

Tumor Size (cm)

7.6 ± 4.1/6.5

Alcohol Drinking

 

Tumor Recurrence

51.1%

   No

60.5

Venous Infiltration

 

   Moderate

23.3

   Absence

50.6%

   Heavy

16.2

   Presence

49.4%

No. of tumor nodule(s)

 

Non-tumorous liver histology

 

   1

76.3

   Cirrhotic

57.1%

   2

6.8

   Non-cirrhotic

14.0%

   3

1.5

   Chronic hepatitis

28.9%

   4

1.1

pTNM Stage

 

   5

0.4

   I

3.0%

   6

0.8

   II

41.1%

   Multiple >6

13.2

   IIIA

35.5%

Edmondson Grade

 

   IV

20.3%

   Undifferentiated

1.3

AJCC Stage

 

   Poorly Differentiated

18.3

   I

41.5%

   Moderate Differentiated

59.2

   II

27.9%

   Well Differentiated

21.3

   IIIA

21.9%

HBsAg Status

 

   IIIB

7.5%

   Positive

86.1

   IV

1.1%

   Negative

13.9

  1. * Drink and smoking data were self-reported: moderate drinking < = 2 drinks/per day; heavy drinking >2 drinks/per day; moderate smoking < = 1 pack/day; heavy smoking >1 pack/day